Study at RCSI Aims to Improve Care for Hemophilia Patients by Using Personalized Approaches

A novel clinical study called “The Irish Personalized Approach to the Treatment of Hemophilia (iPATH)” will seek to investigate the potential of new personalized treatment approaches in hemophilia by tailoring care based on the needs of individual patients. The collaborative study will be led by the Irish Hemophilia Society, in partnership with Shire, a global biotech company that specializes in […]

Read More